Assessing PsA Disease Activity in Clinical Practice

Assessing PsA Disease Activity in Clinical Practice

Assessing PsA Disease Activity in Clinical Practice
RestartResume

Learn how to better monitor the clinical features of PsA over time.

  • Overview

    What are some way we can overcome the challenges that come with monitoring response to therapy for patients with psoriatic arthritis (PsA)? Dr. Ethan Craig is joined by Dr. Alexis Ogdie-Beatty from the Perelman School of Medicine at the University of Pennsylvania to discuss the importance of monitoring and share strategies.

    Dr. Craig and Dr. Ogdie-Beatty are Novartis consultants.

    221663   7/22

Register

We’re glad to see you’re enjoying Rheumatology Academy…
but how about a more personalized experience?

Register for free